Open AccessBleomycin containing chemotherapeutic regimen induced acquired partial lipodystrophy
Author(s) -
Vishal R Tandon,
Novy Gupte,
Vivek Mahajan,
Rahul Sharma,
Cheena Langer,
Vijay Khajuria,
Annil Mahajan
Publication year - 2016
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.174133
Subject(s) - bleomycin , medicine , rash , erythema , regimen , toxicity , dermatology , electrochemotherapy , basal cell , chemotherapy
Bleomycin toxicity predominantly affects the skin and lungs. Cutaneous toxicity classically known to present with bleomycin are flagellate erythema and drug rash. We hereby report an isolated case of (bleomyicn)-induced acquired partial (lipodytrophy) having potential cosmetic implications in a young women prescribed postoperatively following a case of germ cell carcinoma of ovary (endodermal sinus tumor)